GlassScriptPhysician profile
Yifeng Lu
NPI 1417690827
$952.31
in general payments reported to CMS, 2019-2025
11 companies · $709 in 2025
The $709 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $37.65 · 2023: $19.12 · 2024: $186 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $509 · Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $509.19 |
| Food and Beverage | $405.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $509.19 | 2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $122.11 | 2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $104.15 | 2024 | |
| Novo Nordisk INC | $81.57 | 2024-2025 | Wegovy |
| Exact Sciences Corporation | $25.23 | 2024 | Cologuard Collection Kit |
| Organon LLC | $24.13 | 2022 | |
| Impel Pharmaceuticals INC. | $19.12 | 2023 | Trudhesa |
| Cranial Technologies, INC | $18.44 | 2024 | Doc Band |
| Jazz Pharmaceuticals INC. | $17.45 | 2025 | |
| Lilly USA, LLC | $17.40 | 2024 | Mounjaro |
| Abbvie INC. | $13.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yifeng Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.